Everolimus is used to reduce the blood supply of hormone receptor-positive advanced breast cancer in women after menopause, in whom other treatments, advanced tumours called neuroendocrine tumours that originate from the stomach, bowels, lung or pancreas, advanced kidney cancer (advanced renal cell carcinoma), where other treatments (VEGF-targeted therapy) have not helped stop your disease.
Everolimus: Anticancer agents
Everolimus reduces the blood supply to the tumours (hormone receptor-positive advanced breast cancer) and slows down the growth and spread of cancer cells especially in in women after menopause.
Consult your doctor: